Home > Financial Ratios > BAL PHARMA

BAL PHARMA
Core EBITDA Growth

    Back to All Ratios
BAL PHARMA is part of below Screeners ↓
Best 1M Momentum Small Cap Stocks
COMMUNITY POLL
for BAL PHARMA
Please provide your vote to see the results

BAL PHARMA Last 5 Year Core EBITDA Growth History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023Mar2022
   Core EBITDA Growth(%) 6.49-5.3928.99-10.0912.99

What is the latest Core EBITDA Growth ratio of BAL PHARMA ?

The latest Core EBITDA Growth ratio of BAL PHARMA is 6.49 based on Mar2026 Consolidated results.
Year Core EBITDA Growth
Mar20266.49
Mar2025-5.39
Mar202428.99
Mar2023-10.09
Mar202212.99

How is Core EBITDA Growth of BAL PHARMA Trending?

Years Core EBITDA Growth % Change
Mar2026 6.49
Positive
Mar2025 -5.39
Negative
Mar2024 28.99
Positive
Mar2023 -10.09
Negative
Mar2022 12.99 -

Other Financial Ratios of BAL PHARMA


Compare Core EBITDA Growth ratio of peers of BAL PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
BAL PHARMA ₹181.3 Cr 29.2% 30.9% 5.1% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹448,316.0 Cr -1.9% -3.7% 18.9% Stock Analytics
DIVIS LABORATORIES ₹251,737.0 Cr 2.6% 11.1% 56% Stock Analytics
TORRENT PHARMACEUTICALS ₹187,594.0 Cr 0.2% 1.3% 38% Stock Analytics
CIPLA ₹110,515.0 Cr -1.5% -6.4% -12.3% Stock Analytics
DR REDDYS LABORATORIES ₹95,420.6 Cr -1% -5.1% -8.1% Stock Analytics


BAL PHARMA Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
BAL PHARMA

29.2%

30.9%

5.1%

SENSEX

-2.4%

-4.8%

-7.2%


You may also like the below Video Courses